Joint Formulary & PAD

Lorazepam - Anxiety / anticipatory nausea and vomiting

You are here : Home > Formulary Search > Lorazepam - Anxiety / anticipatory nausea and vomiting

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
SPC
Restrictions / Comments :
Important
As per St Luke's protocol for the use of anti-emetics with chemotherapy.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Lorazepam
Indication :
Anxiety / anticipatory nausea and vomiting
Group Name :
Keywords :
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Committee Recommendations (1)

06 Nov 24 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.

Other Indications

Below are listed other indications that Lorazepam is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Anxiety / anticipatory nausea and vomiting.

  • No records returned.